Articles by Oriana Schwindt - Pharmaceutical Executive

ADVERTISEMENT
Articles by Oriana Schwindt
« Previous
123

Zelnorm Returns--Sort Of

Aug 1, 2007
By: Carolynne Van Houten, Oriana Schwindt

Novartis' Zelnorm is back, but only through a restricted-access program.

Pharma Skinny In Briefs

Jul 11, 2007
By: Oriana Schwindt, Walter Armstrong

It was a short, sweaty week complete with fireworks....

Abbott's Risky Strategy In AIDS-drug Struggle

Jun 27, 2007
By: Oriana Schwindt

New lawsuit against activists shows CEO Miles White maverick MO

Pharma Seeing Double, Says New Report

Jun 27, 2007
By: Oriana Schwindt

Global market will be twice as big by 2020, but industry needs new vision

Allez, Alli, But Acomplia, We Hardly Knew Ye

Jun 20, 2007
By: Oriana Schwindt

FDA fears may prevent a showdown between two weight-loss heavyweights.

Sales Slump Linked to Mindless E-mail

Jun 20, 2007
By: Oriana Schwindt

A new study links corporate miscommunication with monetary black holes.

Global Access for Pfizer's New HIV Drug

Jun 20, 2007
By: Oriana Schwindt

Maraviroc's promise shows the value of expanded-access programs

« Previous
123

ADVERTISEMENT

Click here